EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulatory developments in the conduct of clinical trials in India

R Roy Chaudhury, D Mehta

Global Health, Epidemiology and Genomics · 2016

DOI: 10.1017/gheg.2015.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Health, Epidemiology and Genomics, 2016. Verfasst von R Roy Chaudhury und 1 weiteren Autor:innen. Beteiligte Einrichtung: Task Force for Research, Apollo Hospitals Educational and Research Foundation (AHERF), New Delhi, India. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There has been a drop in clinical research in India following stringent conditions put in place by the Indian Supreme Court in 2013. The Court's orders came in the wake of irregularities highlighted in the conduct of clinical trials in the country. This paper highlights the steps taken by the Indian regulator, the Central Drugs Standard Control Organisation to comply with these directions. These are of three kinds: strengthening regulatory institutions, protecting participant safety and creating regulatory certainty for sponsors and investigators. Examples include the large-scale training of Ethics Committees, framing detailed guidelines on compensation and audiovisual recording of the informed consent process, as well as reducing the time taken to process applications. It is expected that these measures will inspire confidence for the much-needed resumption of clinical research.

Schlagwörter

Stichwörter der Autor:innen

Central drugs standard control organisationIndian regulatory frameworkclinical trialsconfidence-building measures

Autor:innen und Institutionen

  • Task Force for Research, Apollo Hospitals Educational and Research Foundation (AHERF), New Delhi, India.
  • Health and Environmental Law, Vidhi Centre for Legal Policy, New Delhi, India.

Zitieren

APA

Roy Chaudhury, R., & Mehta, D. (2016). Regulatory developments in the conduct of clinical trials in India. Global Health, Epidemiology and Genomics. https://doi.org/10.1017/gheg.2015.5

Vancouver

Roy Chaudhury R, Mehta D. Regulatory developments in the conduct of clinical trials in India. Global Health, Epidemiology and Genomics. 2016. doi:10.1017/gheg.2015.5

BibTeX
@article{RoyChaudhury2016,
  author = {Roy Chaudhury, R and Mehta, D},
  title = {Regulatory developments in the conduct of clinical trials in India},
  journal = {Global Health, Epidemiology and Genomics},
  year = {2016},
  doi = {10.1017/gheg.2015.5}
}
Kostenlos starten →